- Patent Title: Method of treating a disease using a glycolytic dependent compound
-
Application No.: US17167428Application Date: 2021-02-04
-
Publication No.: US11986489B2Publication Date: 2024-05-21
- Inventor: James Galloway , Tamara Byk-Tennenbaum , Erez Ilan , Lior Weissman , Sivan Doron , Eve Montia
- Applicant: Ethicon, Inc. , Omrix Biopharmaceuticals Ltd.
- Applicant Address: US NJ Somerville
- Assignee: Ethicon, Inc.,Omrix Biopharmaceuticals Ltd.
- Current Assignee: Ethicon, Inc.,Omrix Biopharmaceuticals Ltd.
- Current Assignee Address: US NJ Raritan; IL Kiryat Ono
- Agent David R. Crichton
- The original application number of the division: US15234177 2016.08.11
- Main IPC: A61K31/717
- IPC: A61K31/717 ; A61K31/704 ; A61L15/28 ; A61L15/44 ; A61L24/00 ; A61L24/08
Abstract:
The present invention is directed to methods of enhancing toxicity of a glycolytic dependent compound towards a cancerous tissue and/or organ in a subject, the method being comprised of targeting the glycolytic dependent compound to the cancerous tissue and/or organ by placing oxidized regenerated cellulose (ORC) and/or oxidized cellulose (OC) in direct connection with the cancerous tissue and/or organ, and administering the glycolytic dependent compound to the subject by a systemic route.
Public/Granted literature
- US20210154224A1 METHOD OF TREATING A DISEASE USING A GLYCOLYTIC DEPENDENT COMPOUND Public/Granted day:2021-05-27
Information query
